Join HSANZ
Congratulations on behalf of all HSANZ to the following members who were honoured recently:
Professor Erica Wood AO from Monash University for distinguished service to transfusion medicine and haemovigilance, to haematology, and to national and international organisations,
Professor Harshall Nandurker AM from Australian Centre for Blood Diseases at Alfred Hospital for significant service to medicine, particularly as a haematologist
Dr Ruth Spearing CNZM for services to haematology. Ruth offered a few words following acceptance of her honour.
I feel as if I am accepting this on behalf of all the NZ haematologists. It was great being the NZ PI for most of the UK studies, especially AML ( though initially also CLL/MM etc) after Mike Beard stepped down in 1993. We managed to get our dreaded Pharmac to agree to pay for the mylotarg in 2015 for AML19 which meant we could take part in that trial which was probably my biggest single achievement! I was very active in medical politics here in NZ for close on 20 years
I feel as if I am accepting this on behalf of all the NZ haematologists.
It was great being the NZ PI for most of the UK studies, especially AML ( though initially also CLL/MM etc) after Mike Beard stepped down in 1993. We managed to get our dreaded Pharmac to agree to pay for the mylotarg in 2015 for AML19 which meant we could take part in that trial which was probably my biggest single achievement!
I was very active in medical politics here in NZ for close on 20 years
HSANZ Scholarships, Fellowships and Awards
HSANZ continues to work with charity and industry partners to offer a range of Scholarships and Grants which are open This year we are offering:
3 x HSANZ / Leukaemia Foundation PhD Scholarships
1 x HSANZ / Arrow Foundation PhD Scholarship
1 x HSANZ / Leukaemia & Blood Cancer New Zealand PhD Scholarship
2 x HSANZ Clinical Fellowships
1 x HSANZ / Snowdome Mid-Career Award
1 x Baikie Award
All above programs close 20 August 2023
1 x HSANZ /ASH Abstract Achievement Award - closes 1 August 2023
All the details are here https://www.hsanz.org.au/scholarships-and-awards/
NHMRC Centre for Blood Transplant and Cell Therapies Webinar 5 July 2023
The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. The second webinar of 2023 features Professor Robert Zeiser, who is a Professor of Medicine and Director of the Division of Tumour Immunology at the Department of Haematology, Oncology and Stem-Cell Transplantation at the Medical Center, University of Freiburg in Freiburg, Germany. His research group has focused on utilizing a range of cutting edge imaging techniques to monitor the fate of different cell types in living animals, leading to several publications in the New England Journal of Medicine, Nature Medicine, Science Translational Medicine, Blood, Nature Communications and the Journal of Clinical Investigation. Professor Zeiser has over 250 peer-reviewed publications and contributed to 14 book chapters. In this webinar, Professor Zeiser will outline the translational pathway of promising, novel therapies for graft vs host disease from murine models into clinical practice. Flyer
Speaker:
Professor Robert Zeiser – University of Freiburg, Germany
When: Wednesday 5 July 2023, 5pm AEST
Link to webinar:
Link to CBTCT website for all webinar recordings:
At the recent very successful HSANZ New Zealand branch meeting in Palmerston North an AGM was held at which there was a discussion about paying tribute to contributors to haematology in NZ. It was agreed to name a session at the annual branch meeting after them in their respective field. It was decided after a vote that the morphology session could be re-named every 10 years after a respected colleague. Edward Theakston who died recently, was to be the new memorial session. An obituary by Anna Ruskova was included in the last HSANZ newsletter.
As New Zealand councillor, Annette Neylon was asked to write a letter to his widow explaining this and HSANZ Council endorsed the proposal unanimously.
The Fellowships are open to researcher and clinicians who are
Full eligibility criteria and application details can be found on the Leukaemia Foundation website
https://www.leukaemia.org.au/research/current-funding-opportunities/research-fellowships/
Make new connections and get your clinical questions answered at Highlights of ASH® in Asia-Pacific this March! Our small meeting is the ideal environment to meet your future colleagues and collaborators. Join us for:
You are cordially invited to attend the HSANZ New Zealand Annual Branch Meeting from 2-4 April 2023.
The program and registration information is attached or click www.spconferences.co.nz/hsanz-2023
Haematology Society of Australia and New Zealand is a partner with ASH for Highlights of ASH in Asia Pacific.
ASH, in partnership with the Hematology and Blood Transfusion Society of Vietnam, are delighted to bring you the official Highlights of ASH® in Asia-Pacific on March 10-11, 2023, in Hanoi, Vietnam. Join us for small-group discussions about the most influential research presented at the 2022 ASH annual meeting, tailored to the Asia-Pacific region. You will:
The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. This webinar features Professor Thomas Luft who is a consultant haematology and oncologist and the taskforce leader for allogeneic haematopoietic stem cell transplant and myelodysplastic syndromes at the Heidelberg University Hospital. Following the completion of his PhD studies at the University of Melbourne, Prof Luft completed post-doctoral fellowships at the Ludwig Institute for Cancer Research in Melbourne as well as the German Cancer Research Centre, where is now the Head of the “Adaptive Immune Regulation” research group. Prof Luft’s research has focused on endothelial complications following allogeneic haematopoietic stem cell transplantation leading to several publications in high impact factor journals and several presentations at international conferences. In this webinar, Prof Luft will be speaking on the early endothelial complications after haematopoeitic stem cell transplant.
Professor Thomas Luft – University of Heidelberg, Heidelberg University Hospital
When: Monday 21 November 2022, 5pm AEDT
For more information click here
The Haematology Society of Australia and New Zealand (HSANZ) and Maddie Riewoldt’s Vision (Maddie’s Vision) are pleased to announce their partnership and commitment to awarding a doctoral scholarship to an Australian or New Zealand applicant demonstrating outstanding merit in both acquired and inherited bone marrow failure syndromes and related disorders.
Maddie’s Vision PhD Research Priorities
This year, Maddie’s Vision and HSANZ will award a PhD scholarship to a successful applicant, whose work contributes to innovative scientific research towards finding new treatments and ultimately cures for both acquired and inherited bone marrow failure syndromes, and aligns with the research priorities of the Maddie’s Vision 5 Pillars of Research:
· Comprehensive clinical data and sample collection on current and newly diagnosed patients with BMF· Genomic and epigenomic control of HSC survival, growth and differentiation · The components and control of the HSC niche · Abnormalities of immune function · Monitoring and predictors of prognosis, response to treatment and disease evolution
Maddie’s Vision and HSANZ PhD Scholarship will:· Provide total funding of no more than $130,000 comprising: · a. a stipend of $40,333 per annum. · b. a consumable budget of up to $3,000 per annum. · Fund each PhD Scholarship for no more than three years of full-time study. · Be dependent on submission of the required annual report to HSANZ and Maddie’s Vision.
Eligibility1. Citizens or permanent residents of either Australia or New Zealand 2. Able to start the PhD in 2023 3. Willing to present their work as an abstract or oral presentation at the annual Scientific Meeting Blood or HSANZ meeting on at least one occasion throughout their Scholarship 4. Willing to participate in publicity and promotional activity organised by Maddie’s Vision5. Be a member of the Haematology Society of Australia and New Zealand www.hsanz.org.au6. Applicants may only receive one PhD scholarship or Clinical Fellowship from the HSANZ during their lifetime 7. Maddie’s Vision HSANZ PhD Scholarship is not to be held in conjunction with another Scholarship, with the exception of tuition fee exemption. If the applicant accepts another PhD scholarship to run concurrently with the Maddie’s Vision HSANZ PhD scholarship, then the Maddie’s Vision HSANZ PhD scholarship will be discontinued.
Applications must contain a:· Research Proposal (5 pages maximum including references) · CV of the applicant (3 pages maximum) · Statement of how the proposed research project directly relates to Maddie’s Vision’s research priorities, and the aims and objectives of the Haematology Society of Australia and New Zealand (1 page maximum) · Written reference from a referee familiar with the applicant’s recent work history (1 page maximum) · Research supervisor report to confirm laboratory support for the research proposal. The report should also comment on the suitability of the applicant for the proposed project and likelihood for successful completion of the project within the proposed time period
Application Procedure1. Applications must be accompanied by all relevant documentation 2. Applications must be submitted in full by midnight AEST on the closing date3. Applicants will submit one electronic (pdf) copy of their scholarship application emailed to HSANZ Office 4. Incomplete or late applications will not be considered 5. Applications will be subject to review by a committee comprised of the HSANZ Council and a representative of Maddie’s Vision. The committee’s decision is final 6. The outcome of applications will be announced mid-August 2022 7. Maddie’s Vision and HSANZ reserve the right to not award a scholarship
Download and share flyer - Final HSANZ Maddie's Vision PhD Scholarship Criteria 2022.pdf
Kindly use this coversheet with your application: MRV HSANZ PhD scholarship application coversheet.pdf
Applications Close: Sunday 6 November 2022 at 11:59 pm AEST
Submitting Electronic (pdf) Applications
Electronic applications, along with all supporting documents should be submitted as a single pdf. The pdf should be named MVHSANZ_PhD2022_[FamilyName] and submitted by email, to HSANZ at admin@hsanz.org.au and Maddie’s Vision at research@mrv.org.au
© 2023 Haematology Society of Australia & New Zealand All Rights Reserved.
Privacy Policy
